Last reviewed · How we verify

HB0045 Drug Product — Competitive Intelligence Brief

HB0045 Drug Product (HB0045 Drug Product) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline.

phase 1 Small molecule Live · refreshed every 30 min

Target snapshot

HB0045 Drug Product (HB0045 Drug Product) — Shanghai Huaota Biopharmaceutical Co., Ltd..

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
HB0045 Drug Product TARGET HB0045 Drug Product Shanghai Huaota Biopharmaceutical Co., Ltd. phase 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). HB0045 Drug Product — Competitive Intelligence Brief. https://druglandscape.com/ci/hb0045-drug-product. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: